Introduction
Through tissue or blood samples, 523 cancer-related genes commonly associated with mutations are analyzed to comprehensively assess all potential treatment options. Based on the identified genetic alterations, matched immunotherapy, targeted therapy, and chemotherapy options are then recommended to help patients find the most suitable personalized treatment plan.
Features / strengths
1. International Standards, Local Services
2. National Laboratory Quality Certification
3. Using NGS Leading Technology
4. Fast and Accurate Report Issuance
5. Complete Clinical Trial Basis
Specification in detail
